Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid

The article further claimed that LEGN hired investment banking firm Centerview Partners to assist its board of directors in reviewing this takeover offer. The article did not provide information on whether this interest could lead to a potential sale. Legend is yet to confirm these reports. In April, the FDA granted label expansion to the J&J-partnered therapy to treat adult patients with MM who have received at least one prior line of therapy, including a proteasome inhibitor (PI) and an immunomodulatory a ...